Johnson & Johnson to pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.
Publishing timestamp: 2024-05-01 09:25:32
Summary
Johnson & Johnson plans to pay $6.5 billion to settle lawsuits claiming its talc-based products caused ovarian cancer. The deal would allow them to resolve most lawsuits through a bankruptcy filing of a subsidiary company. J&J contends their products are safe, but have faced financial and PR trouble. The settlement still needs approval from claimants.
Sentiment: MIXED
Tickers: JNJ,
Keywords: business, pharmaceuticals, biotechnology, johnson & johnson, breaking news: business, health care industry, biotech and pharmaceuticals, business news,